Condition: Coronary Artery Disease · Sponsor: Henan Institute of Cardiovascular Epidemiology
The purpose of this study is to analyze potential factors post paclitaxel drug-coated balloon angioplasty in patients with Denovo large vessels disease. It includes imaging endpoints and clinical event endpoints. Over 5000 patients are expected to be enrolled.
This description comes directly from the study's public registry record.
Quan Guo, MD · +8615670510031 · xinyiguoquan@163.com
Always discuss trial participation with your own doctor first.
| Fuwai Central China Cardiovascular Hospital | Zhengzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06620458